Astec LifeSciences Limited
Astec LifeSciences Limited, together with its subsidiaries, manufactures and sells agrochemical active ingredients and pharmaceutical intermediates in India. The company provides triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maiz… Read more
Market Cap & Net Worth: Astec LifeSciences Limited (ASTEC)
Astec LifeSciences Limited (NSE:ASTEC) has a market capitalization of $150.63 Million (₹13.04 Billion) as of March 18, 2026. Listed on the NSE stock exchange, this India-based company holds position #22854 globally and #1178 in its home market, demonstrating a -7.49% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Astec LifeSciences Limited's stock price ₹585.45 by its total outstanding shares 22281661 (22.28 Million).
Astec LifeSciences Limited Market Cap History: 2015 to 2026
Astec LifeSciences Limited's market capitalization history from 2015 to 2026. Data shows growth from $62.22 Million to $150.63 Million (9.04% CAGR).
Index Memberships
Astec LifeSciences Limited is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY MICROCAP 250
NIFTYMICROCAP250
|
$68.11 Billion | 0.05% | #224 of 250 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$1.32 Trillion | 0.00% | #680 of 750 |
Weight: Astec LifeSciences Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Astec LifeSciences Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Astec LifeSciences Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.05x
Astec LifeSciences Limited's market cap is 0.05 times its annual revenue
4.22x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $156.95 Million | $2.59 Billion | -$191.64 Million | 0.06x | N/A |
| 2017 | $140.19 Million | $2.99 Billion | $191.18 Million | 0.05x | 0.73x |
| 2018 | $134.94 Million | $3.61 Billion | $349.04 Million | 0.04x | 0.39x |
| 2019 | $116.62 Million | $4.31 Billion | $357.37 Million | 0.03x | 0.33x |
| 2020 | $331.08 Million | $5.23 Billion | $475.11 Million | 0.06x | 0.70x |
| 2021 | $367.83 Million | $5.55 Billion | $650.49 Million | 0.07x | 0.57x |
| 2022 | $449.99 Million | $6.77 Billion | $898.59 Million | 0.07x | 0.50x |
| 2023 | $281.79 Million | $6.28 Billion | $255.65 Million | 0.04x | 1.10x |
| 2024 | $257.09 Million | $4.58 Billion | -$469.30 Million | 0.06x | N/A |
| 2025 | $181.38 Million | $3.81 Billion | -$1.35 Billion | 0.05x | N/A |
Competitor Companies of ASTEC by Market Capitalization
Companies near Astec LifeSciences Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Astec LifeSciences Limited by market ranking:
- Corteva Inc (NYSE:CTVA): Ranked #406 globally with a market cap of $53.70 Billion USD.
- Nutrien Ltd (NYSE:NTR): Ranked #615 globally with a market cap of $34.02 Billion USD.
- Qinghai Salt Lake Industry Co.Ltd (SHE:000792): Ranked #1164 globally with a market cap of $16.27 Billion USD ( CN¥119.40 Billion CNY).
- CF Industries Holdings Inc (NYSE:CF): Ranked #1215 globally with a market cap of $15.33 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #406 | Corteva Inc | NYSE:CTVA | $53.70 Billion | $80.05 |
| #615 | Nutrien Ltd | NYSE:NTR | $34.02 Billion | $79.55 |
| #1164 | Qinghai Salt Lake Industry Co.Ltd | SHE:000792 | $16.27 Billion | CN¥36.15 |
| #1215 | CF Industries Holdings Inc | NYSE:CF | $15.33 Billion | $123.29 |
Astec LifeSciences Limited Historical Marketcap From 2015 to 2026
Between 2015 and today, Astec LifeSciences Limited's market cap moved from $62.22 Million to $ 150.63 Million, with a yearly change of 9.04%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₹150.63 Million | -16.96% |
| 2025 | ₹181.38 Million | -29.45% |
| 2024 | ₹257.09 Million | -8.77% |
| 2023 | ₹281.79 Million | -37.38% |
| 2022 | ₹449.99 Million | +22.34% |
| 2021 | ₹367.83 Million | +11.10% |
| 2020 | ₹331.08 Million | +183.89% |
| 2019 | ₹116.62 Million | -13.57% |
| 2018 | ₹134.94 Million | -3.75% |
| 2017 | ₹140.19 Million | -10.68% |
| 2016 | ₹156.95 Million | +152.26% |
| 2015 | ₹62.22 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Astec LifeSciences Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $150.63 Million USD |
| MoneyControl | $150.63 Million USD |
| MarketWatch | $150.63 Million USD |
| marketcap.company | $150.63 Million USD |
| Reuters | $150.63 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.